18 /100
LOW RISK
Score updated May 29, 2026

STOK — Stoke Therapeutics, Inc. Dilution Risk Tracker

Track STOK dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track STOK — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
35
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for STOK.
🔔 Track STOK — Get forecast alerts →

💹 Market Data

Market Cap$1.97B
Shares Outstanding62.28M
Float46.76M
Cash$343.54M
Debt$3.42M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 2.2% shares (2025Q4 vs prior)
185 institutional holders · 68.08M shares
#1 FMR LLC 5.60M shares
#2 RTW INVESTMENTS, LP 5.55M shares
#3 Lynx1 Capital Management LP 5.40M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest13.03M
Days to Cover27.0
% of Float27.9%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track STOK Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking STOK — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for STOK
📊 STOK FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 STOK Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.